Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoStart with Pro — $79/mo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskNeutral

Burzynski Research Institute, Inc.

burzynskiresearch.com
Filed: Apr 17, 2026CIK: 0000724445Health Care
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Stanislaw R. Burzynski, M.D., Ph.D. was appointed as Chief Financial Officer and Secretary on April 17, 2026, following the resignation of Patryk P. Goscianski. This leadership transition in financial management may signal strategic shifts in the company's financial direction.

Key Takeaways

Patryk P. Goscianski resigned as CFO and Secretary effective April 17, 2026, with no reported disagreements with the company

Stanislaw R. Burzynski, M.D., Ph.D. was immediately appointed to replace him as CFO and Secretary on the same date

2 more takeaways

Filing Overview

Form Type8-K
Filing DateApr 17, 2026
Item5.02
CategoryExecutive Change
CIK0000724445
Accession #0000724445
Risk LevelMEDIUM
SentimentNeutral
Signalinformational
Topics
leadership transitionexecutive departureexecutive hire

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings